LIVE

NGVT

Ingevity Corporation

NGVT

NYSE·Basic Materials·Chemicals - Specialty·Mkt cap $2.5B

$72.49

-0.12%

View full research view

Our plain-language verdict, the thesis, risk factors, and what is changing about the business.

View research view

52-Week Range

$39.74 - $79.29

P/E

-20.59

Fwd P/E

14.70

Beta

1.19

Div Yield

0.00%

Avg Vol

264.4K

Shares Out

35.3M

Mkt Cap

$2.5B

Price action

Price chart

Up 55.1% over the trailing year

1W
1M
3M
6M
YTD
1Y
5Y
MAX

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

Bull Case

4 reasons

  • Integrated supply chain leveraging kraft pulping byproducts for sustainable raw materials
  • Specialized expertise in activated carbon engineering for critical automotive emissions compliance
  • Diversified end-market exposure across automotive, infrastructure, oil & gas, and industrial applications
  • Proprietary technology in pavement preservation and advanced polymer chemistry

Bear Case

1 risk

  • Average volatility.

Growth

Turning profitable

Stricter global vehicle emissions regulations driving demand for activated carbon solutions

Value

Attractively priced below Specialty Chemicals peer average

Momentum

Stable

+2.1% over 3m

Quality

Stable

Strong fundamentals

Dividend

None

No dividend

Earnings track record

Latest print - beat on both lines

AI-summarized recap of last quarter, plus the surprise on every print.

Next: May 4, 2026

Q2 26 RECAP

MAY 6, 2026

Reported EPS of $1.15 vs $0.84 consensus (+36.9% surprise). Revenue of $258.0M vs $254.7M expected (+1.3%). Beat on both top and bottom lines.

EPS beat +36.9%
Rev beat +1.3%
Double beat

EPS surprise · last 4Q

1 of 1 beats

Q2 26

+36.9%

Next: May 4, 2026

Revenue trend · last 8Q

-20%

-16%

-7%

-12%

-15%

-9%

Q2 24

Q3 24

Q4 24

Q1 25

Q2 25

Q3 25

Q4 25

Q1 26

$390.6M

$376.9M

$298.8M

$284.0M

$365.1M

$333.1M

$255.1M

$258.0M

Margins · last 8Q

Gross

Operating

Profit

23.2%

Wall Street consensus

1 analyst · 0% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

0%

Hold

1

100%

Sell

0%

Median Price Target

Latest: BMO Capital · $83.00 · Mar 2, 2026

vs Industry

How NGVT stacks vs Chemicals - Specialty

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.